VectorXcellerator Programme: Fully funded feasibility studies to support early-stage cell and gene therapy programmes
Webinar: Optimising viral vector manufacturing with CDMO expertise and innovation
News: OXB honoured at 2025 CDMO Leadership Awards Europe in ‘Cell & Gene Therapy’ category
Visit our refreshed resource centre for the latest case studies, research posters and more.
